Last Updated: 02/12/2024

Safety and protective efficacy of a simplified Plasmodium falciparum sporozoite chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany

Objectives

To test the safety and protective efficacy of a simplified Plasmodium falciparum sporozoite chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany.

Principal Institution

Tübingen University, Germany

Principal Investigators / Focal Persons

Zita Sulyok

Study Design

  • Allocation: Randomized controlled trial
  • Masking: Blinded (patient/subject, investigator/therapist)
  • Control: Placebo
  • Assignment: Parallel
  • Study design purpose: Prevention

Themes

Vaccines

Date

Jun 2019 — Mar 2020

Funding Details
Project Site

Germany

SHARE
SHARE